Laboratory Centrifuges Market Size, Share, Growth, and Industry Analysis, By Type (Benchtop Centrifuges,Floor-Standing Centrifuges), By Application (Diagnostics,Microbiology,Cellomics,Genomics,Proteomics,Blood Component Separation,Others), Regional Insights and Forecast to 2035

Laboratory Centrifuges Market Overview

The global Laboratory Centrifuges Market size is projected to grow from USD 2234.57 million in 2026 to USD 2370.66 million in 2027, reaching USD 3804.71 million by 2035, expanding at a CAGR of 6.09% during the forecast period.

The Laboratory Centrifuges Market supports separation of particles, cells, nucleic acids, proteins, and blood components by leveraging centrifugal force, covering benchtop, floor-standing, and ultra-centrifuge classes, with global shipments exceeding ~300,000 units annually and replacement rotor sales accounting for an additional ~20 % of unit revenues.

In the United States, the laboratory centrifuge sector is among the most mature: U.S. laboratories operate over 50,000 benchtop centrifuges and 5,000 floor-standing centrifuges, with annual rotor replacement cycles averaging 2 to 3 rotations per device.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 65 % of labs allocate capital to upgrade centrifuge performance.
• Major Market Restraint: 30 % of small labs cite cost of high-speed models as barrier.
• Emerging Trends: 40 % of new models launched in 2023 offer IoT connectivity.
• Regional Leadership: North America commands ~35 % share of global device installs.
• Competitive Landscape: Top two manufacturers hold ~30 % of global market share.
• Market Segmentation: Benchtop models represent about 60 % of shipments.
• Recent Development: 25 % of rotor designs introduced in 2024 enabled multiplexing.

Laboratory Centrifuges Market Latest Trends

Key trends in the Laboratory Centrifuges Market include the proliferation of smart, connected centrifuges — in 2023–2024, over 40 % of new centrifuge models included built-in sensors for vibration monitoring, cloud telemetry, and preventative alerts, enabling remote maintenance and performance optimization. Another trend is the rise of multiplex rotor designs that allow simultaneous processing of different tube sizes; ~25 % of new rotor products in 2024 supported dual-format (e.g., 15 mL + 50 mL) capacity. Miniaturization continues: microcentrifuges with volumes under 2 mL gained adoption in 20 % of new molecular labs installed in 2023.

Laboratory Centrifuges Market Dynamics

The Laboratory Centrifuges Market Dynamics are driven by a combination of rising biomedical research activities, expanding diagnostic infrastructure, and continuous technological upgrades across laboratory equipment design, automation, and digital integration. Globally, over 300,000 centrifuges are actively in use across hospital laboratories, diagnostic centers, and pharmaceutical manufacturing facilities, highlighting the indispensable role centrifugation plays in modern research and clinical workflows.

DRIVER

"Expansion of molecular diagnostics, biopharma, and personalized medicine drives centrifuge demand."

As molecular diagnostics and genomics grow, laboratories require high-throughput centrifugation for DNA/RNA extraction, viral vector purification, and liquid biopsy workflows; in 2023, over 15,000 new molecular labs were commissioned globally. The vaccine and biologic production surge demands large-scale centrifuges for cell harvesting, boosting purchases of floor-standing and ultracentrifuges. Academic and research grant programs increased instrument funding by ~12 % in 2023, fueling new lab setups.

RESTRAINT

"High capital cost, maintenance complexity, and space requirements hinder penetration in small labs."

High-speed and refrigerated centrifuges cost several times more than basic models; many smaller clinical labs find them unaffordable. Maintenance — rotor balancing, sealing, calibration — demands skilled technicians; about 20 % of downtime in 2023 was due to service issues. Floor-standing units require significant lab space, and many labs in urban settings cannot accommodate them. Fewer than 30 % of labs replace centrifuges every 7 years; many operate beyond intended life.

OPPORTUNITY

"Mid-tier, modular, and retrofit solutions open access to under-penetrated laboratories."

Modular centrifuges that allow future upgrade paths are bridging budget and performance gaps; ~12 new modular product lines launched in 2023. Retrofit kits converting legacy centrifuges to smart-connected units grew ~30 % in 2024. Leasing and instrument-as-a-service models are gaining traction — several OEMs now deploy centrifuge-as-a-service contracts in over 50 labs in 2024. Emerging markets like Southeast Asia and Latin America show underserved lab density: new diagnostic and research labs there increased ~18 % in 2023.

CHALLENGE

"Ensuring reliability, rotor safety, and regulatory validation is demanding."

Centrifuges must endure high mechanical stress; rotor failure is a safety risk — manufacturers report < 0.1 % failure rates annually but such failures attract recalls. Qualification for diagnostics or pharmaceutical use often demands validation cycles of 6–12 months (e.g., 100,000 cycles test), delaying deployment. Balancing precision, noise, and vibration control is technically challenging; about 5 % of shipments in 2023 required aftermarket retrofits. Certification standards differ across geographies, complicating export compliance for OEMs.

Laboratory Centrifuges Market Segmentation

The Laboratory Centrifuges Market segments by Type (Benchtop Centrifuges, Floor-Standing Centrifuges) and Application (Diagnostics, Microbiology, Cellomics, Genomics, Proteomics, Blood Component Separation, Others). Benchtop centrifuges account for ~60 % of shipments, while floor-standing units contribute ~40 %. In applications, Diagnostics holds ~25 %, Microbiology ~15 %, Genomics/Proteomics ~20 %, Cellomics ~10 %, Blood Component Separation ~15 %, and Others ~15 %. This segmentation is central to Laboratory Centrifuges Market Analysis and Market Forecast.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

• Benchtop Centrifuges: Benchtop centrifuges are compact models used in clinical labs, research benches, and academic settings; they represent about 60 % of global shipments. Frequently offered with capacities of 24–48 × 1.5/2 mL rotor formats, many are refrigerated with speeds up to 15,000 rpm. Such models account for over 100,000 units in use worldwide across diagnostic facilities. The compact footprint allows deployment even in small labs; nearly 70 % of new diagnostic lab installs in 2023 selected benchtop versions. Consumable rotors, adapters, and maintenance services drive recurring revenue, representing ~10–15 % of total hardware value over lifespan.
• Floor-Standing Centrifuges: Floor-standing centrifuges serve high throughput, large capacity, and industrial or bioprocess applications, and represent ~40 % of unit value in the market. Many support tube count 500+ or bucket rotors for volumes > 1 L. They are common in large diagnostic labs, biopharma production, cell manufacturing, and core facilities. Over 5,000 floor-standing units are estimated globally in advanced clinical/bioprocess labs. Adoption requires dedicated floor space and infrastructure support (vibration isolation, power) — limiting penetration in smaller facilities. Performance, durability, and safety features (e.g., imbalance detection) are critical, and replacement cycles tend to be longer, enhancing total lifetime service revenue.

BY APPLICATION

• Diagnostics: The Diagnostics segment accounts for nearly 25% of the global Laboratory Centrifuges Market, driven by widespread use in clinical testing, disease screening, and sample separation processes. Over 20,000 diagnostic laboratories worldwide operate centrifuges for plasma, serum, and hematology workflows. Benchtop and compact centrifuges dominate, comprising around 70% of diagnostic installations. Automation and high reliability are crucial, with hospitals and diagnostic centers replacing units every 6–8 years. The increasing number of chronic disease tests, routine clinical procedures, and advanced testing programs across over 120 countries continues to expand centrifuge adoption in diagnostic facilities globally.
• Microbiology: The Microbiology application represents approximately 15% of the global Laboratory Centrifuges Market, primarily serving bacterial culture, cell pelleting, and pathogen isolation workflows. Over 10,000 microbiology labs globally use benchtop centrifuges, with 40% operating refrigerated models for sensitive microbial specimens. Compact centrifuges capable of speeds above 14,000 rpm are standard in modern microbiology facilities. Academic and pharmaceutical R&D institutions heavily invest in advanced centrifugation for biosafety and contamination control. Rotor versatility and ease of cleaning are vital factors in procurement decisions. Continuous advancements in containment and aerosol-tight rotors enhance operational safety and efficiency in microbiology laboratories worldwide.
• Cellomics: The Cellomics segment accounts for around 10% of the Laboratory Centrifuges Market, focused on cell-based research, imaging assays, and sample fractionation. Approximately 3,000 specialized laboratories globally use centrifuges for cell analysis, drug discovery, and high-content screening. Low-speed refrigerated centrifuges are preferred to preserve cell viability, with typical capacity ranging from 24 to 48 tube configurations. Multiwell plate-compatible rotors, used in 25% of cellomics labs, have become critical for automation integration. Pharmaceutical and academic cell biology facilities increasingly demand vibration-minimized centrifuges, enhancing reproducibility in assays. Continuous innovation in rotor design supports precision-driven workflows across global cellomics research and biotechnology facilities.
• Genomics: The Genomics application holds roughly 20% of the Laboratory Centrifuges Market, driven by next-generation sequencing (NGS), DNA/RNA purification, and molecular biology research. More than 5,000 genomic laboratories worldwide deploy benchtop centrifuges for sample preparation and nucleic acid isolation. High-speed microcentrifuges operating at 15,000–21,000 rpm dominate genomic workflows due to their precision and compactness. Many genomic labs integrate centrifuges within automated sequencing pipelines to reduce manual handling. Manufacturers are emphasizing rotor flexibility and low vibration levels to ensure sample integrity. The rapid expansion of molecular diagnostics and personalized medicine research further strengthens global centrifuge demand in genomics-based laboratories.
• Proteomics: The Proteomics segment represents approximately 10% of the Laboratory Centrifuges Market, supporting protein purification, molecular separation, and structural analysis. Around 2,000 proteomics laboratories globally operate high-speed and ultracentrifuges for precise biomolecule separation. These devices typically function between 50,000 and 100,000 g, making them essential for subcellular and protein complex fractionation. The surge in proteomic biomarker discovery has led to a 15% increase in centrifuge usage across pharmaceutical and research organizations in 2024. Rotor material durability, high thermal stability, and automation compatibility are central to adoption. Demand for large-volume and precision-controlled centrifuges continues to expand in proteomics laboratories worldwide.
• Blood Component Separation: The Blood Component Separation segment comprises around 15% of the Laboratory Centrifuges Market, driven by global blood banking, transfusion services, and plasma processing applications. Over 3,000 blood banks and transfusion centers rely on floor-standing centrifuges for platelet, plasma, and red blood cell separation. Typical capacity ranges from 4 to 12 blood bags per cycle, with automated balancing systems reducing manual workload by 25%. Many national health programs adopted standardized centrifuge models for uniformity in blood processing. The growing need for safe blood storage, transfusion efficiency, and component quality assurance continues to drive centrifuge adoption across public and private healthcare systems.
• Others: The Others category accounts for roughly 15% of the Laboratory Centrifuges Market, encompassing environmental labs, pharmaceutical manufacturing, industrial QC testing, and academic research institutes. Around 10,000 centrifuges are deployed across these diverse applications annually. General-purpose and universal centrifuges dominate, offering multi-sample flexibility with speed ranges up to 18,000 rpm. Many government-funded institutions and environmental agencies utilize centrifuges for chemical, pollutant, and microbial testing. Demand is particularly strong in Asia and Latin America, where infrastructure expansion supports the establishment of new public laboratories. This diverse segment underlines the adaptability and broad scientific importance of centrifugation across multiple industries worldwide.

Regional Outlook for the Laboratory Centrifuges Market

The Laboratory Centrifuges Market Regional Outlook highlights strong geographic diversification, with North America holding approximately 35% of global installations supported by over 55,000 centrifuge units, while Europe contributes around 25%, emphasizing technological advancement and sustainable lab infrastructure. The Asia-Pacific region commands nearly 30% of total demand, led by China, Japan, and India, where rapid diagnostic expansion and biopharma research drive equipment adoption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In North America, the laboratory centrifuge market commands approximately 35 % of global unit installations, with the U.S. accounting for ~80 % of regional demand. Over 50,000 benchtop and 5,000 floor-standing centrifuges are in active use across clinical, academic, and biotech entities. States regularly allocate over USD 200 million annually to instrumentation grants, of which centrifuges represent a core share. Many U.S. labs upgrade rotors or systems every 5–7 years; rotor replacement cycles (2–3 per device) drive sustained service revenue. Canada and Mexico contribute the balance, with Mexico adopting new centrifuge deployments in ~250 labs per year and Canada performing upgrades in provincial research centers. The strong regulatory, funding, and research environment in North America ensures consistent demand for next-gen, connected centrifuge systems.

The North America Laboratory Centrifuges Market dominated the global industry, valued at approximately USD 674.0 million in 2025, representing 32.0% of total market share, driven by strong biopharmaceutical manufacturing capabilities, high laboratory automation rates, and robust government support for research and clinical diagnostics infrastructure. The region benefits from extensive investment in genomic sequencing, precision medicine, and clinical testing, alongside continuous technology upgrades across academic and industrial laboratories. Leading manufacturers in the United States, supported by innovation-focused policies, drive the production and export of high-speed and refrigerated centrifuges. The growing use of advanced centrifugation systems in diagnostics, proteomics, and molecular biology continues to position North America as a global innovation hub for laboratory equipment.

North America - Major Dominant Countries in the “Laboratory Centrifuges Market”

• United States: The United States held a market value of USD 438.1 million in 2025, accounting for 65.0% of regional share, and remains the primary contributor due to widespread adoption of high-speed centrifuges in biopharmaceutical manufacturing, clinical diagnostics, and genomic research laboratories nationwide.
• Canada: Canada’s market reached USD 121.3 million in 2025, representing 18.0% share, supported by government-backed health research programs, growth in academic laboratories, and rising installations of benchtop centrifuges in diagnostic and industrial testing applications.
• Mexico: Mexico recorded a market valuation of USD 67.4 million in 2025, representing 10.0% share, driven by infrastructure modernization in medical and pharmaceutical sectors, expansion of diagnostic laboratories, and increasing partnerships with global equipment suppliers.
• Brazil: Brazil achieved USD 33.9 million in 2025, accounting for 5.0% of North America’s share, propelled by new laboratory construction initiatives, adoption of automated centrifuge units, and government investments in biotechnological and healthcare modernization programs.
• Others: The rest of the North American market collectively contributed USD 13.5 million in 2025, representing 2.0% share, driven by steady adoption across smaller laboratories, regional universities, and specialized life science research centers.

EUROPE

Europe retains ~25 % of global laboratory centrifuge installations, with Germany, France, the U.K., Italy, and Spain leading. European labs operate over 20,000 benchtop and 2,500 floor-standing centrifuges within diagnostics, research, and biopharma sectors. EU research grants fund ~800 new lab instrumentation packages annually, many including centrifuges. Shared infrastructure in pan-European consortia boosts cross-border deployment and standardization. Many facilities in Europe prioritize low-noise, energy-efficient, and connected models; about 30 % of new centrifuge purchases in 2023–2024 included IoT-enabled features. Regulatory harmonization (CE marking, safety directives) supports vendor entry across the region. Academic, pharmaceutical, and public labs frequently coordinate bulk procurement to gain volume discounts, solidifying Europe’s strong institutional base in the Laboratory Centrifuges Market.

The Europe Laboratory Centrifuges Market accounted for approximately USD 569.0 million in 2025, representing 27.0% of the global market share, and continues to strengthen due to its advanced research and development infrastructure, strict laboratory equipment certification regulations, and rapid adoption of precision centrifuge technologies across biotechnology, genomics, and clinical diagnostics sectors. The region’s dominance is reinforced by the strong presence of globally recognized centrifuge manufacturers, extensive university-led research programs, and government-supported initiatives focused on improving laboratory automation and sustainable technology adoption in healthcare systems. Continuous innovation in rotor engineering, temperature-controlled centrifugation, and noise-reduction technology are among the critical factors accelerating growth across Europe, as laboratories increasingly shift toward energy-efficient and precision-driven equipment for improved analytical performance.

Europe - Major Dominant Countries in the “Laboratory Centrifuges Market”

• Germany: Germany held a market value of USD 170.7 million in 2025, accounting for 30.0% of Europe’s share, and remains a key manufacturing hub supported by a large network of analytical instrument producers, pharmaceutical companies, and biotechnological research facilities driving centrifuge integration in quality control and production environments.
• United Kingdom: The United Kingdom reached a market valuation of USD 102.4 million in 2025, representing 18.0% share, driven by strong investments in national diagnostic infrastructure, laboratory expansion under the NHS research programs, and continuous funding toward genomic medicine and life sciences innovation across public and private research institutions.
• France: France recorded a market value of USD 85.3 million in 2025, representing 15.0% share, sustained by the country’s rapid adoption of laboratory automation systems, modernization of clinical diagnostic facilities, and growing number of research collaborations in molecular biology and genomics that require high-speed centrifugation accuracy.
• Italy: Italy’s Laboratory Centrifuges Market achieved a valuation of USD 68.2 million in 2025, capturing 12.0% share, supported by healthcare modernization programs, digital transformation of industrial testing centers, and the establishment of new academic laboratories focusing on pharmaceutical and proteomic research.
• Spain: Spain contributed USD 56.9 million in 2025, holding 10.0% of the regional share, and is projected to expand further due to increased academic research funding, installation of automated benchtop centrifuge units in hospitals, and a growing emphasis on laboratory equipment standardization across universities and public health institutions.

ASIA-PACIFIC

The Asia-Pacific region is the fastest expanding portion of the Laboratory Centrifuges Market, driving nearly 30 % of global unit uptake. Key growth markets include China, India, Japan, South Korea, and Southeast Asia. China alone contributes over 40 % of regional device shipments, with domestic manufacturers supplying many benchtop systems. India’s biotech and diagnostics sectors installed ~1,200 new centrifuges in 2023. Japan and South Korea invest heavily in diagnostics and genomics infrastructure. Many new labs in Southeast Asia adopt compact benchtop models due to space constraints. Regional OEMs capture ~60 % of new lower-cost unit demand, while global brands supply premium models. Governments in China, India, and Malaysia launched lab infrastructure subsidies in 2023, accelerating demand. Asia-Pacific also sees growing export of centrifuge consumables and rotor components to global buyers, making it both a consumption and manufacturing hub in the Laboratory Centrifuges Market.

The Asia Laboratory Centrifuges Market accounted for USD 738.0 million in 2025, representing 35.0% of global market share, emerging as the fastest-growing regional segment due to rapid advancements in biotechnology, rising healthcare spending, and strong governmental support for clinical diagnostics infrastructure development. The region’s technological landscape is defined by local manufacturing competitiveness, extensive laboratory expansion in hospitals and universities, and increasing demand for precision instruments across research and pharmaceutical industries. The Asia-Pacific region serves as both a leading production hub and a key consumer market, with significant installations across China, Japan, India, and South Korea supporting diagnostic modernization and scientific innovation.

Asia - Major Dominant Countries in the “Laboratory Centrifuges Market”

• China: China dominated the region with a market value of USD 295.2 million in 2025, representing 40.0% of Asia’s share, supported by large-scale diagnostic expansion, increased government funding for biotechnology, and the establishment of over 1,000 modernized research laboratories.
• Japan: Japan’s market was valued at USD 147.6 million in 2025, accounting for 20.0% share, driven by its strong focus on life sciences R&D, investment in genomic research, and advanced laboratory automation practices across clinical institutions.
• India: India achieved USD 110.7 million in 2025, representing 15.0% share, propelled by growing healthcare infrastructure, increased diagnostic testing demand, and rising adoption of mid-range benchtop centrifuges in hospital laboratories and biotech startups.
• South Korea: South Korea’s market reached USD 88.6 million in 2025, accounting for 12.0% share, expanding through high R&D intensity, adoption of precision lab automation, and active governmental investment in biomedical innovation centers.
• Singapore: Singapore contributed USD 66.4 million in 2025, representing 9.0% of Asia’s share, driven by world-class laboratory infrastructure, international research collaborations, and increased imports of high-performance centrifuge systems for proteomic and genomic applications.

MIDDLE EAST & AFRICA

The Middle East & Africa (MEA) region holds about 5–7 % of the global laboratory centrifuge market. Major demand centers exist in Gulf countries (UAE, Saudi Arabia, Qatar) and in South Africa, Egypt, and Nigeria. In 2023, Saudi Arabia procured over 800 new benchtop units for diagnostic and research labs; UAE laboratories expanded rotor replacements across 200 units. In Africa, Nigeria and South Africa renewed budgets for 150 new centrifuge systems in medical and academic sectors. Many new installations in MEA adopt lower-cost, compact models and retrofit legacy units for connectivity. Often procurement is bundled with lab equipment infrastructure projects. Climate challenges — heat, dust, humidity — drive demand for rugged, refrigerated, and vibration-resistant designs. As research and healthcare investment rises, MEA becomes a strategic growth zone for centrifuge OEMs in the Laboratory Centrifuges Market Outlook.

The Middle East and Africa Laboratory Centrifuges Market reached an estimated USD 126.3 million in 2025, representing 6.0% of global market share, supported by rapid healthcare infrastructure development, industrial diversification, and increasing government focus on research-based laboratory modernization programs. The region is witnessing steady growth due to expanding hospital networks, emerging biotechnology centers, and partnerships between global centrifuge manufacturers and regional distributors to meet evolving laboratory demands. Countries across the GCC and Africa are investing in laboratory training and equipment standardization to enhance diagnostic accuracy and research capabilities across academic and clinical environments.

Middle East and Africa - Major Dominant Countries in the “Laboratory Centrifuges Market”

• United Arab Emirates: The UAE held a market size of USD 37.8 million in 2025, representing 30.0% of regional share, driven by strong government spending on research infrastructure, advanced hospital laboratories, and digital transformation of healthcare services.
• Saudi Arabia: Saudi Arabia recorded USD 31.5 million in 2025, accounting for 25.0% share, supported by healthcare reforms, increased investment in national research centers, and adoption of modern centrifuge systems across public and private hospitals.
• South Africa: South Africa achieved USD 25.2 million in 2025, representing 20.0% of regional share, driven by expansion of diagnostic laboratories, blood banks, and biopharmaceutical manufacturing facilities across major metropolitan areas.
• Egypt: Egypt’s market was valued at USD 18.9 million in 2025, accounting for 15.0% share, fueled by laboratory expansion projects in academic institutions and collaborations between universities and international equipment suppliers.
• Nigeria: Nigeria contributed USD 12.6 million in 2025, representing 10.0% share, driven by development of healthcare infrastructure, donor-funded laboratory programs, and rising focus on public health testing across regional medical centers.

List of Top Laboratory Centrifuges Companies

• Sigma Laborzentrifugen GmbH
• Danaher Corporation
• Koki Holdings Co. Ltd.
• Becton, Dickinson and Company
• NuAire
• GTCR LLC
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Kubota Corporation
• HERMLE Labortechnik GmbH
• Sanofi Pasteur
• QIAGEN N.V.
• Eppendorf AG
• Andreas Hettich GmbH & Co. KG

Thermo Fisher Scientific Inc.: Leading global supplier with over 20% market share, offering advanced centrifuge systems across diagnostics, research, and biopharmaceutical applications.

Eppendorf AG: Renowned manufacturer holding approximately 15% global share, specializing in precision benchtop centrifuges, microcentrifuges, and automated sample processing equipment for laboratories worldwide.

Investment Analysis and Opportunitie

Investment in the Laboratory Centrifuges Market continues to gain momentum, driven by rising clinical diagnostics demand, genomics research growth, and biopharma expansion. In 2023–2024, leading centrifuge manufacturers invested over USD 150 million in R&D and manufacturing capacity. Startups offering modular, IoT-enabled rotors and retrofit kits attracted ~USD 25 million in funding rounds. Leasing models and instrument-as-a-service offerings expanded, with ~10 % of new devices procured under subscription in 2024.

New Product Development

Recent product innovation in the Laboratory Centrifuges Market emphasizes connectivity, flexibility, energy efficiency, and miniaturization. In 2023–2024, over 25 new centrifuge models were launched featuring cloud connectivity, predictive maintenance alerts, and real-time vibration diagnostics. Many units incorporate adaptive speed profiles allowing gradual acceleration to reduce sample stress. Modular rotor adapters that support multiple tube sizes in one rotor emerged in ~15 new designs. Refrigerated mini-centrifuges with reduced power consumption (~15 % lower) were introduced for small labs. Battery-powered portable centrifuges capable of 10,000 rpm were released for field diagnostics, capturing ~5 % of portable demand.

Five Recent Developments

• In 2024, a major OEM introduced a smart centrifuge line with built-in vibration sensors and cloud diagnostic services across 50 global labs.
• In 2023, an instrument company launched modular rotor adapters enabling mixing of tube sizes, adopted by ~200 labs.
• In 2025, a startup released battery-powered portable centrifuges achieving 10,000 rpm for remote diagnostics.
• In 2024, a manufacturer rolled out composite carbon-fiber rotors reducing weight by ~30 % and increasing durability in high-speed units.
• In 2025, a global firm deployed over-the-air firmware updates enabling new speed profiles and IoT diagnostics in ~1,000 installed devices.

Report Coverage of Laboratory Centrifuges Market

This Laboratory Centrifuges Market Report encompasses global and regional market sizing, segmentation, technology evolution, competitive dynamics, investment analysis, and product innovation. It covers market sizing by Type (Benchtop and Floor-Standing) and Application (Diagnostics, Microbiology, Cellomics, Genomics, Proteomics, Blood Separation, Others). Regional chapters profile North America, Europe, Asia-Pacific, and Middle East & Africa, including country-level deployment trends and regulatory influences. The report offers Laboratory Centrifuges Market Analysis, Market Insights, Market Forecast, and Market Opportunities targeting OEMs, lab instrument distributors, service providers, and investors.

Laboratory Centrifuges Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2234.57 Million in 2026
Market Size Value By	USD 3804.71 Million by 2035
Growth Rate	CAGR of 6.09% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Benchtop Centrifuges Floor-Standing Centrifuges By Application : Diagnostics Microbiology Cellomics Genomics Proteomics Blood Component Separation Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample